Soreide Law Group has been contacted by investors who purchased Gemphire Therapeutics Inc. (GEMP) and experienced stock losses through the sale of the stock brokers at Laidlaw and Company. Laidlaw is listed on their website as the “Co-Manager” from the March of 2017 offering. Often, securities that are newly issued are more volatile than the more […]